[Click eStock] "Pharmaresearch, Stock Price Upward This Year Due to 'Rejuran' Sales Growth"

Esthetic specialist company PharmaResearch is expected to show an upward stock price trend this year based on the sales growth of its flagship product, ‘Rejuran’.

On the 28th, the Korea IR Association Corporate Research Center stated in a corporate analysis report, “PharmaResearch’s brand power and performance growth of Rejuran, the original domestic skin booster, result in a higher valuation compared to similar companies, which may be a burden.” The center projected PharmaResearch’s price-to-earnings ratio (PER) for this year at 25.3 times, higher than similar companies such as Hugel (23.2 times), Daewoong Pharmaceutical (12.0 times), Medytox (16.8 times), and APR (16.4 times). However, the center explained, “With full-scale entry into Europe underway and expected customer base expansion in South America and the Middle East, the valuation is at a justifiable level.”

PharmaResearch’s sales for this year are estimated at 418.2 billion KRW, a 19.6% increase from the previous year. The center explained, “Domestic sales of medical devices are expected to show stable growth due to increased demand for procedures targeting both domestic and foreign tourists for Rejuran, and export sales of medical devices are projected to increase by 43.8% year-on-year due to expansion of European operations.” The cosmetics division is also expected to achieve double-digit growth following the previous year, driven by rising brand awareness of Rejuran.

The center noted, “In a situation where competition in the PDRN (polydeoxyribonucleotide) and PN (polynucleotide) markets, which PharmaResearch focuses on, is intensifying, the launch and rapid market establishment of Rejuran in Europe is a critical point,” adding, “It could serve as an important reference for future entry into the U.S. market, so it is necessary to confirm early performance growth.”

PharmaResearch is a regenerative bio-specialized company that develops pharmaceuticals, medical devices, and cosmetics containing PDRN and PN components extracted and purified from salmon germ cells’ DNA.

This content was produced with the assistance of AI translation services.